Divestments and COVID-19 drag down GSK’s sales

3 May 2021 - Deborah Wilkes

Premium

GlaxoSmithKline (GSK) Consumer Healthcare reported a significant drop in sales during the first quarter of 2021 as divestments and the COVID-19 pandemic took their toll.

Click tags below for more information on topics:

GlaxoSmithKline COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: